Dihydromyricetin and Salvianolic acid B inhibit alpha-synuclein aggregation and enhance chaperone-mediated autophagy

[1]  Yujin Guo,et al.  Salvianolic acid B protects against lipopolysaccharide-induced behavioral deficits and neuroinflammatory response: involvement of autophagy and NLRP3 inflammasome , 2017, Journal of Neuroinflammation.

[2]  Stuart M Phillips,et al.  Differential localization and anabolic responsiveness of mTOR complexes in human skeletal muscle in response to feeding and exercise. , 2017, American journal of physiology. Cell physiology.

[3]  Xifan Mei,et al.  The Role of Netrin-1 in Improving Functional Recovery through Autophagy Stimulation Following Spinal Cord Injury in Rats , 2017, Front. Cell. Neurosci..

[4]  Xiao-Ling Wang,et al.  Salvianolic acid B protects hepatocytes from H2O2 injury by stabilizing the lysosomal membrane , 2017, World journal of gastroenterology.

[5]  J. Waddington,et al.  Dihydromyricetin exerts a rapid antidepressant-like effect in association with enhancement of BDNF expression and inhibition of neuroinflammation , 2017, Psychopharmacology.

[6]  Hui Xu,et al.  AKT/mTOR signaling pathway is involved in salvianolic acid B-induced autophagy and apoptosis in hepatocellular carcinoma cells. , 2016, International journal of oncology.

[7]  Zili You,et al.  Salvianolic acid B ameliorates depressive-like behaviors in chronic mild stress-treated mice: involvement of the neuroinflammatory pathway , 2016, Acta Pharmacologica Sinica.

[8]  Xue-chu Zhen,et al.  Dihydromyricetin protects neurons in an MPTP-induced model of Parkinson's disease by suppressing glycogen synthase kinase-3 beta activity , 2016, Acta Pharmacologica Sinica.

[9]  G. Gao,et al.  Chaperone-Mediated Autophagy and Mitochondrial Homeostasis in Parkinson's Disease , 2016, Parkinson's disease.

[10]  A. Bilia,et al.  Development of Blood-Brain Barrier Permeable Nanoparticles as Potential Carriers for Salvianolic Acid B to CNS , 2016, Planta Medica.

[11]  G. Halliday,et al.  Lysosomal‐associated membrane protein 2 isoforms are differentially affected in early Parkinson's disease , 2015, Movement disorders : official journal of the Movement Disorder Society.

[12]  M. Mi,et al.  Dihydromyricetin improves skeletal muscle insulin resistance by inducing autophagy via the AMPK signaling pathway , 2015, Molecular and Cellular Endocrinology.

[13]  W. Xiong,et al.  Dihydromyricetin protects endothelial cells from hydrogen peroxide-induced oxidative stress damage by regulating mitochondrial pathways. , 2015, Life sciences.

[14]  M. Mi,et al.  Dihydromyricetin improves skeletal muscle insulin sensitivity by inducing autophagy via the AMPK-PGC-1α-Sirt3 signaling pathway , 2015, Endocrine.

[15]  S. Menon,et al.  Ginsenoside Rb1 inhibits fibrillation and toxicity of alpha-synuclein and disaggregates preformed fibrils , 2015, Neurobiology of Disease.

[16]  G. Braus,et al.  Systematic Comparison of the Effects of Alpha-synuclein Mutations on Its Oligomerization and Aggregation , 2014, PLoS genetics.

[17]  J. Winkler,et al.  Autophagy modulates SNCA/α-synuclein release, thereby generating a hostile microenvironment , 2014, Autophagy.

[18]  N. Tjandra,et al.  Structure of Transmembrane Domain of Lysosome-associated Membrane Protein Type 2a (LAMP-2A) Reveals Key Features for Substrate Specificity in Chaperone-mediated Autophagy* , 2014, The Journal of Biological Chemistry.

[19]  Liang Le,et al.  Dihydromyricetin ameliorates the oxidative stress response induced by methylglyoxal via the AMPK/GLUT4 signaling pathway in PC12 cells , 2014, Brain Research Bulletin.

[20]  Ying Sun,et al.  Multiple pathogenic proteins implicated in neuronopathic Gaucher disease mice. , 2014, Human molecular genetics.

[21]  Jie Zhou,et al.  Salvianolic Acid B Attenuates Toxin-Induced Neuronal Damage via Nrf2-Dependent Glial Cells-Mediated Protective Activity in Parkinson’s Disease Models , 2014, PloS one.

[22]  R. Olsen,et al.  Dihydromyricetin Ameliorates Behavioral Deficits and Reverses Neuropathology of Transgenic Mouse Models of Alzheimer’s Disease , 2014, Neurochemical Research.

[23]  Bin Liu,et al.  Dihydromyricetin induces autophagy in HepG2 cells involved in inhibition of mTOR and regulating its upstream pathways. , 2014, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[24]  A. Cuervo,et al.  Chaperone-mediated autophagy: roles in disease and aging , 2013, Cell Research.

[25]  Wei Zhou,et al.  Dihydromyricetin Reduced Bcl-2 Expression via p53 in Human Hepatoma HepG2 Cells , 2013, PloS one.

[26]  P. Brundin,et al.  A novel α-synuclein-GFP mouse model displays progressive motor impairment, olfactory dysfunction and accumulation of α-synuclein-GFP , 2013, Neurobiology of Disease.

[27]  N. Fineberg,et al.  Dopamine and its metabolites in cathepsin D heterozygous mice before and after MPTP administration , 2013, Neuroscience Letters.

[28]  H. Ischiropoulos,et al.  Regional deficiencies in chaperone-mediated autophagy underlie α-synuclein aggregation and neurodegeneration , 2012, Neurobiology of Disease.

[29]  Yang Liu,et al.  Direct Stimulation of Adult Neural Stem/Progenitor Cells In Vitro and Neurogenesis In Vivo by Salvianolic Acid B , 2012, PloS one.

[30]  Jihye Park,et al.  Autophagy-regulating small molecules and their therapeutic applications. , 2012, Chemical Society reviews.

[31]  B. Hyman,et al.  Distinct Roles In Vivo for the Ubiquitin–Proteasome System and the Autophagy–Lysosomal Pathway in the Degradation of α-Synuclein , 2011, The Journal of Neuroscience.

[32]  A. Giese,et al.  Inhibition and disaggregation of α‐synuclein oligomers by natural polyphenolic compounds , 2011, FEBS letters.

[33]  Z. Fei,et al.  Salvianolic acid B attenuates brain damage and inflammation after traumatic brain injury in mice , 2011, Brain Research Bulletin.

[34]  Steve D. M. Brown,et al.  α-Synuclein impairs macroautophagy: implications for Parkinson’s disease , 2010, The Journal of cell biology.

[35]  K. Caldwell,et al.  Low‐dose bafilomycin attenuates neuronal cell death associated with autophagy‐lysosome pathway dysfunction , 2010, Journal of neurochemistry.

[36]  Jie Zeng,et al.  Characterization and antioxidant activity of dihydromyricetin–lecithin complex , 2009 .

[37]  P. Saftig,et al.  Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function , 2009, Nature Reviews Molecular Cell Biology.

[38]  David Park,et al.  Abberant α-Synuclein Confers Toxicity to Neurons in Part through Inhibition of Chaperone-Mediated Autophagy , 2009, PloS one.

[39]  Paul C. Wang,et al.  Salvianolic acid B inhibits growth of head and neck squamous cell carcinoma in vitro and in vivovia cyclooxygenase‐2 and apoptotic pathways , 2009, International journal of cancer.

[40]  Fang Yang,et al.  MPP+ impairs autophagic clearance of alpha-synuclein by impairing the activity of dynein , 2009, Neuroreport.

[41]  M. Gearing,et al.  Regulation of Neuronal Survival Factor MEF2D by Chaperone-Mediated Autophagy , 2009, Science.

[42]  Kostas Vekrellis,et al.  Wild Type α-Synuclein Is Degraded by Chaperone-mediated Autophagy and Macroautophagy in Neuronal Cells* , 2008, Journal of Biological Chemistry.

[43]  M. Xilouri,et al.  Alpha-synuclein degradation by autophagic pathways: A potential key to Parkinson’s Disease pathogenesis , 2008, Autophagy.

[44]  J. N. Rao,et al.  Characterization of alpha-synuclein interactions with selected aggregation-inhibiting small molecules. , 2008, Biochemistry.

[45]  W. Klein,et al.  Salvianolic acid B inhibits Aβ fibril formation and disaggregates preformed fibrils and protects against Aβ-induced cytotoxicty , 2008, Neurochemistry International.

[46]  Peter T Lansbury,et al.  Dopamine-modified alpha-synuclein blocks chaperone-mediated autophagy. , 2008, The Journal of clinical investigation.

[47]  D. Rubinsztein,et al.  Potential therapeutic applications of autophagy , 2007, Nature Reviews Drug Discovery.

[48]  J. Dice.  Chaperone-Mediated Autophagy , 2007, Autophagy.

[49]  D. Rubinsztein,et al.  The roles of intracellular protein-degradation pathways in neurodegeneration , 2006, Nature.

[50]  Jochen Klucken,et al.  Detection of novel intracellular O‐synuclein oligomeric species by fluorescence lifetime imaging , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[51]  Xue-jun Li,et al.  Salvianolic acid B, an antioxidant from Salvia miltiorrhiza, prevents Abeta(25-35)-induced reduction in BPRP in PC12 cells. , 2006, Biochemical and biophysical research communications.

[52]  Masaaki Komatsu,et al.  Loss of autophagy in the central nervous system causes neurodegeneration in mice , 2006, Nature.

[53]  Hideyuki Okano,et al.  Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice , 2006, Nature.

[54]  Kenjiro Ono,et al.  Antioxidant compounds have potent anti‐fibrillogenic and fibril‐destabilizing effects for α‐synuclein fibrils in vitro , 2006, Journal of neurochemistry.

[55]  J. Growdon,et al.  Clinical and biochemical correlates of insoluble alpha-synuclein in dementia with Lewy bodies. , 2006, Acta neuropathologica.

[56]  J. Growdon,et al.  Clinical and biochemical correlates of insoluble α-synuclein in dementia with Lewy bodies , 2006, Acta Neuropathologica.

[57]  M. Forgac,et al.  Involvement of the Nonhomologous Region of Subunit A of the Yeast V-ATPase in Coupling and in Vivo Dissociation* , 2004, Journal of Biological Chemistry.

[58]  Peter T. Lansbury,et al.  Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy , 2004, Science.

[59]  R. Lüllmann-Rauch,et al.  Disturbed cholesterol traffic but normal proteolytic function in LAMP-1/LAMP-2 double-deficient fibroblasts. , 2004, Molecular biology of the cell.

[60]  Jochen Klucken,et al.  Hsp70 Reduces α-Synuclein Aggregation and Toxicity* , 2004, Journal of Biological Chemistry.

[61]  Leonidas Stefanis,et al.  Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. , 2004, Science.

[62]  T. Dawson,et al.  Molecular Pathways of Neurodegeneration in Parkinson's Disease , 2003, Science.

[63]  Jeremy N. Skepper,et al.  α-Synuclein Is Degraded by Both Autophagy and the Proteasome* , 2003, Journal of Biological Chemistry.

[64]  J. Trojanowski,et al.  Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease. , 2002, Science.

[65]  John Q. Trojanowski,et al.  Chaperone Suppression of α-Synuclein Toxicity in a Drosophila Model for Parkinson's Disease , 2001, Science.

[66]  Peter T. Lansbury,et al.  Kinetic Stabilization of the α-Synuclein Protofibril by a Dopamine-α-Synuclein Adduct , 2001, Science.

[67]  B. Hyman,et al.  Interaction of α‐synuclein and synphilin‐1: effect of Parkinson's disease‐associated mutations , 2001 .

[68]  B. Hyman,et al.  Interaction of alpha-synuclein and synphilin-1: effect of Parkinson's disease-associated mutations. , 2001, Journal of neurochemistry.

[69]  G. Du,et al.  Salvianolic Acid B Protects the Memory Functions against Transient Cerebral Ischemia in Mice , 2000, Journal of Asian natural products research.

[70]  R. Lüllmann-Rauch,et al.  Normal Lysosomal Morphology and Function in LAMP-1-deficient Mice* , 1999, The Journal of Biological Chemistry.

[71]  M. L. Schmidt,et al.  α-Synuclein in Lewy bodies , 1997, Nature.